WO1999018086A1 - Verfahren zur herstellung von triazolinthion-derivaten - Google Patents

Verfahren zur herstellung von triazolinthion-derivaten Download PDF

Info

Publication number
WO1999018086A1
WO1999018086A1 PCT/EP1998/006111 EP9806111W WO9918086A1 WO 1999018086 A1 WO1999018086 A1 WO 1999018086A1 EP 9806111 W EP9806111 W EP 9806111W WO 9918086 A1 WO9918086 A1 WO 9918086A1
Authority
WO
WIPO (PCT)
Prior art keywords
carbon atoms
formula
optionally substituted
derivatives
alkyl
Prior art date
Application number
PCT/EP1998/006111
Other languages
German (de)
English (en)
French (fr)
Inventor
Reinhard Lantzsch
Manfred Jautelat
Achim Hupperts
David Erdman
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Priority to KR20007003071A priority Critical patent/KR100555367B1/ko
Priority to EP98958843A priority patent/EP1021420B1/de
Priority to DK98958843T priority patent/DK1021420T3/da
Priority to BRPI9812895-7A priority patent/BR9812895B1/pt
Priority to AT98958843T priority patent/ATE235473T1/de
Priority to US09/509,889 priority patent/US6271389B1/en
Priority to JP2000514897A priority patent/JP4028172B2/ja
Priority to IL13487598A priority patent/IL134875A/xx
Priority to DE59807672T priority patent/DE59807672D1/de
Priority to HU0100103A priority patent/HU228840B1/hu
Priority to AU14847/99A priority patent/AU1484799A/en
Publication of WO1999018086A1 publication Critical patent/WO1999018086A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Definitions

  • the prior invention relates to a new process for the preparation of t ⁇ azothionate derivatives which are known as active ingredients with microbicidal, in particular fungicidal, properties
  • T ⁇ azo nthion-De ⁇ vate can be prepared by either reacting the corresponding T ⁇ azol-De ⁇ vate either in succession with strong bases and sulfur and then hydrolyzing or reacting directly with sulfur at high temperatures and then treating with water (see WO -A 96-16 048)
  • the disadvantage of these processes is that the desired products are obtained only in relatively low yields or that reaction conditions are required which are difficult to maintain on an industrial scale
  • R 1 and R 2 are identical or different and represent optionally substituted alkyl, optionally substituted alkenyl, optionally substituted cycloalkyl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aroxyalkyl, optionally substituted aryl or optionally substituted heteroaryl,
  • R 1 and R 2 have the meanings given above, with carbonyl compounds of the formula
  • R 3 represents alkyl having 1 to 4 carbon atoms or phenyl
  • R 4 represents hydrogen or alkyl having 1 to 4 carbon atoms or
  • R 3 and R 4 together represent a - (CH 2 ) 5 chain
  • X represents sodium, potassium or ammonium
  • R 1 , R 2 , R 3 and R 4 have the meanings given above,
  • the process according to the invention is distinguished by a number of advantages. As already mentioned, it enables the synthesis of tnazo nthiones of the formula (I) in high yield. It is also favorable that the required starting materials and reaction components can be prepared easily and are also available in large amounts Finally, there is a further advantage that the implementation of the individual reaction steps and the isolation of the reaction products pose no difficulties If 2- (1-chloro-cyclopropyl) -3- (2-chlorophenyl) -2-hydroxypropyl-1-hydrazine is used as the starting substance and this is reacted in the first stage with acetone and potassium thiocyanate and left that If t ⁇ azohdinthion devat obtained in the second stage react with formic acid, the course of the process according to the invention can be illustrated by the following formula scheme
  • Formula (II) provides a general definition of the hydrazine derivatives required as starting materials when carrying out the process according to the invention.
  • R represents straight-chain or branched alkyl having 1 to 6 carbon atoms, it being possible for these radicals to be monosubstituted to quadruple, identical or different, by halogen, alkoxy having 1 to 4 carbon atoms,
  • aryl part or represents aralkyl having 6 to 10 carbon atoms in the aryl part and 1 to 4 carbon atoms in the straight-chain or branched alkyl part, where the aryl part can in each case be substituted once to three times, identically or differently, by halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio with 1 to 4 carbon atoms, haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different
  • alkyl having 1 to 4 carbon atoms alkoxy having 1 to 4 carbon atoms
  • Alkylthio with 1 to 4 carbon atoms haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms
  • haloalkoxy with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms haloalkylthio with 1 or 2 carbon atoms and 1 to 5 identical or various halogen atoms
  • aroxyalkyl having 6 to 10 carbon atoms in the aryl part and 1 to 4 carbon atoms in the straight-chain or branched oxyalkyl part where the aryl part can in each case be substituted once to three times, identically or differently, by halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio with 1 to 4 carbon atoms, haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkoxy with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkylthio with 1 or 2 carbon atoms and 1 up to 5 identical or different halogen atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl, phenoxy, alkoxycarbonyl with 1 to 4 carbon atoms in the alkoxy part, alkoximinoalkyl with 1 to 4
  • aryl having 6 to 10 carbon atoms where each of these radicals can be substituted once to three times, identically or differently by halogen, alkyl having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, alkylthio having 1 to 4 carbon atoms, haloalkyl 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms,
  • alkoxy with 1 or 2 carbon atoms alkoxy with 1 or 2 carbon atoms, alkylthio with 1 or 2 carbon atoms, haloalkyl, haloalkoxy and haloalkylthio each with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, such as fluorine or chlorine atoms, formyl, dialkoxymethyl with 1 or 2 carbon atoms in each alkoxy group, acyl with
  • alkoxycarbonyl with 1 to 4 carbon atoms in the alkoxy part
  • alkoximinoalkyl with 1 to 4 carbon atoms in the alkoxy part and 1 to 3 carbon atoms in the alkyl part, nitro and / or cyano
  • alkyl having 1 to 6 carbon atoms, where these radicals can be substituted up to four times, in the same way or differently, by halogen, alkoxy with 1 to 4 carbon atoms, alkoximino with 1 to 4 carbon atoms in the alkoxy part and / or cycloalkyl with 3 to 7 carbon atoms,
  • alkyl having 1 to 4 carbon atoms alkoxy having 1 to 4 Carbon atoms
  • alkylthio with 1 to 4 carbon atoms haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms
  • haloalkoxy with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms haloalkylthio with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms
  • alkyl having 1 to 4 carbon atoms alkoxy having 1 to 4 carbon atoms
  • Alkylthio with 1 to 4 carbon atoms haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms
  • haloalkoxy with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms haloalkylthio with 1 or 2 carbon atoms and 1 to 5 identical or different Halogen atoms
  • aroxyalkyl having 6 to 10 carbon atoms in the aryl part and 1 to 4 carbon atoms in the straight-chain or branched oxyalkyl part where the aryl part can in each case be substituted once to three times, identically or differently, by halogen, alkyl having 1 to 4 carbon atoms, alkoxy by 1 to 4 carbon atoms, alkylthio with 1 to 4 carbon atoms, haloalkyl with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkoxy with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, haloalkylthio with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, cycloalkyl with 3 to 7 carbon atoms, phenyl, phenoxy, alkoxycarbonyl with 1 to 4 carbon atoms in the alkoxy part, alkoximinoalkyl with 1 to 4 carbon
  • benzanellated five- or six-membered heteroaromatic radical with 1 to 3 heteroatoms, such as nitrogen, sulfur and / or oxygen where each of these radicals can be monosubstituted to trisubstituted, identical or different, by halogen, alkyl having 1 to 4 carbon atoms, Hydroxyalkyl with 1 to 4 carbon atoms, hydroxyalkynyl with 3 to 8 carbon atoms, alkoxy with 1 or 2 carbon atoms, alkylthio with 1 or 2 carbon atoms, flalogenalkyl, haloalkoxy and haloalkylthio each with 1 or 2 carbon atoms and 1 to 5 identical or different halogen atoms, such as fluorine - or chlorine atoms, formyl, di- O 99/18086
  • alkoxymethyl with 1 or 2 carbon atoms in each alkoxy group
  • acyl with 2 to 4 carbon atoms
  • alkoxycarbonyl with 1 to 4 carbon atoms in the alkoxy part
  • alkoximinoalkyl with 1 to 4 carbon atoms in the alkoxy part and 1 to 3 carbon atoms in the alkyl part
  • Rl represents straight-chain or branched alkyl having 1 to 4 carbon atoms, it being possible for these radicals to be substituted one to four times, in the same way or differently, by fluorine, chlorine, bromine, methoxy, ethoxy,
  • each of these radicals can be substituted once to three times, identically or differently, by fluorine, chlorine, bromine, cyano, methyl, ethyl, propyl, isopropyl and / or tert-butyl,
  • phenylalkyl having 1 to 4 carbon atoms in the straight-chain or branched alkyl part, where the phenyl part can be substituted once to three times, in the same way or differently, by fluorine, chlorine, bromine, methyl,
  • phenylalkenyl having 2 to 4 carbon atoms in the alkenyl part, where the phenyl part can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert. -Butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenoxyalkyl having 1 to 4 carbon atoms in the straight-chain or branched oxyalkyl part, where the phenyl part can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, methyl, ethyl, tert.
  • phenyl which can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, methyl, ethyl, tert. Butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenylalkyl having 1 to 4 carbon atoms in the straight-chain or branched alkyl part, where the phenyl part can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, methyl, Ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano
  • phenylalkenyl having 2 to 4 carbon atoms in the alkenyl part, where the phenyl part can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert. -Butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio,
  • -Butyl, where these radicals can be substituted one to four times, in the same way or differently, by fluorine, chlorine, bromine, methoxy, ethoxy, propoxy, isopropoxy, methoximino, ethoximino, cyclopropyl, cyclobutyl, cyclopentyl and / or cyclohexyl,
  • phenylalkyl having 1 or 2 carbon atoms in the straight-chain or branched alkyl part, where the phenyl part can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert.
  • phenylalkenyl having 2 to 4 carbon atoms in the alkenyl part, where the phenyl part can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert. -Butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenoxyalkyl having 1 to 4 carbon atoms in the straight-chain or branched oxyalkyl part, where the phenyl part can be mono- to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, Methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenyl which can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, Methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano, or for pyrazolyl, imidazolyl, 1,2,4-triazolyl, pyrrolyl, furanyl, thienyl, thiazolyl, oxazolyl, pyridinyl, pyrimidinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, in
  • Benzimidazolyl stands, where each of these radicals can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, chlorodifluoromethylthio , Hydroxymethyl, hydroxy ethyl, hydroxyalkynyl with 4 to 6
  • n-propyl represents n-propyl, isopropyl, n-butyl, i-butyl, sec-butyl or tert-butyl, it being possible for these radicals to be substituted one to four times, identically or differently, by fluorine, chlorine, bromine, methoxy, ethoxy, Propoxy, isopropoxy, methoximino, ethoximino, cyclopropyl, cyclobutyl, cyclopentyl and / or cyclohexyl,
  • phenylalkyl having 1 or 2 carbon atoms in the straight-chain or branched alkyl part, where the phenyl part can be substituted once to three times, in the same way or differently, by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl , Trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenylalkenyl having 2 to 4 carbon atoms in the alkenyl part, where the phenyl part can be substituted once to three times, in the same way or differently, by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy , Trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenoxyalkyl having 1 to 4 carbon atoms in the straight-chain or branched oxyalkyl part, where the phenyl part can be mono- to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, Methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano,
  • phenyl which can be monosubstituted to trisubstituted, identical or different, by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, difluoromethoxy, chlorodifluoromethylthio, Methoxycarbonyl, ethoxycarbonyl, methoximinomethyl, 1-methoximinoethyl, nitro and / or cyano, or for pyrazolyl, imidazolyl, 1,2,4-triazolyl, pyrrolyl, furanyl, thienyl, thiazolyl, oxazolyl, pyridinyl, pyrimidinyl, triazinyl, quinolinyl, isoquinolinyl, quinazolinyl, in
  • Benzimidazolyl where each of these radicals can be monosubstituted to triple, identical or differently substituted by fluorine, chlorine, bromine, methyl, ethyl, tert-butyl, methoxy, ethoxy, methylthio, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, chlorodifluoromethoxy, chlorodifluoromethylthio , Hydroxymethyl, hydroxyethyl, hydroxyalkynyl with 4 to 6
  • the hydrazine derivatives of the formula (II) are known or can be prepared by processes which are known in principle (cf. DE-A-40 30 039).
  • hydrazine derivatives of the formula (II) are obtained by using 1-chloro-2-hydroxy-ethane derivatives of the formula
  • the 1-chloro-2-hydroxyethane derivatives of the formula (VI) and also the oxirane derivatives of the formula (VII) are known or can be prepared by processes known in principle (see DE-A-40 30 039 and EP- A 0 2397 345)
  • Diluents used in the above process for the preparation of hydrazine derivatives of the formula (II) are all customary inert, organic solvents
  • Question Alcohols such as methanol, ethanol or n-butanol, furthermore ethers such as dioxane or methyl tert-butyl ether, and furthermore aromatic hydrocarbons such as benzene, toluene or xylene can preferably be used.
  • ethers such as dioxane or methyl tert-butyl ether
  • aromatic hydrocarbons such as benzene, toluene or xylene
  • hydrazine hydrate is used in excess, so that it functions both as a reaction component and as a diluent
  • reaction temperatures in the preparation of hydrazine derivatives of the formula (II) can be varied within a certain range by the above process. In general, temperatures between 60 ° C and 120 ° C, preferably between 70 ° C and 110 ° C.
  • hydrazine derivatives of the formula (II) In the preparation of hydrazine derivatives of the formula (II) by the above process, 1 mol of 1-chloro-2-hydroxy-ethane derivative of the formula (VT) or of oxuan derivative of the formula (VII) in general is used 1 to 20 mol, preferably 5 to 15 mol, of hydrazine hydrate. Working up is carried out by customary methods. The general procedure is that the reaction mixture is admixed with a water-immiscible organic solvent, such as methyl tert-butyl ether or toluene. the aqueous phase is separated off, the organic phase is washed and dried
  • the carbonyl compounds required as reaction components when carrying out the first stage of the process according to the invention are represented by the formula (III) generally defined Carbonyl compounds of the formula (III) in which
  • R 3 represents methyl, ethyl, n-propyl, isopropyl, n-butyl, tert-butyl or phenyl and
  • R 4 represents hydrogen, methyl, ethyl, n-propyl or n-butyl or
  • R 3 and R 4 together represent a - (CH 2 ) 5 chain
  • R 3 represents methyl, ethyl, n-propyl, isopropyl, tert-butyl or phenyl and
  • R 4 represents hydrogen, methyl, ethyl or n-propyl or
  • R 3 and R 4 together represent a - (CH 2 ) 5 chain
  • Suitable diluents for carrying out the first stage of the process according to the invention are all inert organic solvents customary for such reactions.
  • Aromatic hydrocarbons such as benzene, toluene or xylene, and furthermore ethers, such as dioxane, methyl tert-butyl ether, 1, are preferably used.
  • an excess of carbonyl compound of the formula (III) can also function as a diluent
  • Suitable acids when carrying out the first stage of the process according to the invention are customary inorganic or organic acids.
  • Hydrochloric acid, sulfuric acid or p-toluenesulfonic acid are preferably usable
  • reaction temperatures can be varied within a substantial range when carrying out the first stage of the process according to the invention. In general, temperatures between 0 ° C and 120 ° C, preferably between 10 ° C and 110 ° C.
  • Both the first and the second stage of the process according to the invention are carried out in general under atmospheric pressure. However, it is also possible to work under increased pressure or, if no gaseous components are involved in the reaction, under reduced pressure
  • t ⁇ azolidinthione derivatives of the formula (V) have hitherto not been known. They can be produced by the implementation in the first stage of the process according to the invention
  • Suitable catalysts for carrying out the second stage of the process according to the invention are all reaction accelerators customary for reactions of this type.
  • acids such as hydrochloric acid, sulfuric acid or p-toluenesulfonic acid and metal oxides such as amorphous titanium dioxide can be used.
  • Suitable diluents for carrying out the second stage of the process according to the invention are all weakly polar organic solvents which are customary for such reactions.
  • Alcohols such as propanol, butanol or pentanol, and further esters, such as ethyl acetate, butyl acetate or isobutyl formate, and furthermore ethers, are also suitable , such as 1,2-dimethoxyethane, methyl tert -butyl ether or methyl tert -amyl ether, and also formic acid in excess
  • reaction temperatures can be varied within a certain range when carrying out the second stage of the process according to the invention. In general, temperatures between 80 ° C. and 150 ° C., preferably between 90 ° C. and 130 ° C.
  • the process according to the invention can be carried out by reacting l-chloro-2-hydroxyethane derivatives of the formula (VI) or oxirane derivatives of the formula (VII) with hydrazine hydrate and the hydrazine Derivatives of formula (II) then without prior isolation and
  • triazolinethione derivatives of the formula (I) can also be prepared by
  • R 1 and R 2 each have the meanings given above,
  • R 1 and R 2 have the meanings given above,
  • R 3 represents alkyl having 1 to 4 carbon atoms or phenyl
  • R 4 represents hydrogen or alkyl having 1 to 4 carbon atoms or
  • R 3 and R 4 together represent a - (CH 2 ) 5 chain
  • X represents sodium, potassium or ammonium
  • R 1 , R 2 , R 3 and R 4 have the meanings given above,
  • triazolinethione derivatives which can be prepared according to the invention are known as active ingredients with microbicidal, in particular fungal, properties (cf. WO-A 96-16048).
  • 2-Hydroxy-propyl-l-hydrazine and 300 ml of 2N aqueous hydrochloric acid are mixed with stirring at room temperature first with 8.2 g (0.14 mol) of acetone and then with 13.6 g (0.14 mol) of potassium thiocyanate the reaction mixture is mixed with 100 ml of toluene and stirred for a further 10 hours at room temperature. The resulting solid is then filtered off, washed with water and then with toluene and dried.
  • Phase from solid precipitation This process is repeated once more with 100 ml of water.
  • 150 ml of 2N aqueous hydrochloric acid, 4.1 g (0.07 mol) of acetone, 6.8 g (0.07 mol) of potassium thiocyanate and 50 ml of toluene are added to the product obtained.
  • the reaction mixture is stirred for 12 hours at room temperature and then filtered.
  • the filter residue is washed successively with water and toluene and then dried.
  • 1 1.6 g of triazolidinethione derivative of the formula given above is obtained in the form of a colorless, crystalline solid substance with a melting point of 186 to 187 ° C.
  • the yield is calculated at 62.0% of theory, based on the 1-chloro-2-hydroxy-ethane used.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PCT/EP1998/006111 1997-10-08 1998-09-25 Verfahren zur herstellung von triazolinthion-derivaten WO1999018086A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
KR20007003071A KR100555367B1 (ko) 1997-10-08 1998-09-25 트리아졸린티온 유도체의 제조방법
EP98958843A EP1021420B1 (de) 1997-10-08 1998-09-25 Verfahren zur herstellung von triazolinthion-derivaten
DK98958843T DK1021420T3 (da) 1997-10-08 1998-09-25 Fremgangsmåde til fremstilling af triazolinthionderivater
BRPI9812895-7A BR9812895B1 (pt) 1997-10-08 1998-09-25 derivados de triazolintiona, bem como processo para sua preparação.
AT98958843T ATE235473T1 (de) 1997-10-08 1998-09-25 Verfahren zur herstellung von triazolinthion- derivaten
US09/509,889 US6271389B1 (en) 1997-10-08 1998-09-25 Method for producing triazolinethione derivatives
JP2000514897A JP4028172B2 (ja) 1997-10-08 1998-09-25 トリアゾリンチオン誘導体の製造方法
IL13487598A IL134875A (en) 1997-10-08 1998-09-25 Method for producing triazolinethione derivatives
DE59807672T DE59807672D1 (de) 1997-10-08 1998-09-25 Verfahren zur herstellung von triazolinthion-derivaten
HU0100103A HU228840B1 (en) 1997-10-08 1998-09-25 Methods for producing triazolinethione derivatives
AU14847/99A AU1484799A (en) 1997-10-08 1998-09-25 Method for producing triazolinethione derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19744401A DE19744401A1 (de) 1997-10-08 1997-10-08 Verfahren zur Herstellung von Triazolinthion-Derivaten
DE19744401.6 1997-10-08

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09/509,889 A-371-Of-International US6271389B1 (en) 1997-10-08 1998-09-25 Method for producing triazolinethione derivatives
US09/750,589 Division US6372916B2 (en) 1997-10-08 2000-12-28 Method for producing triazolinethione derivatives

Publications (1)

Publication Number Publication Date
WO1999018086A1 true WO1999018086A1 (de) 1999-04-15

Family

ID=7844918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/006111 WO1999018086A1 (de) 1997-10-08 1998-09-25 Verfahren zur herstellung von triazolinthion-derivaten

Country Status (15)

Country Link
US (2) US6271389B1 (zh)
EP (1) EP1021420B1 (zh)
JP (1) JP4028172B2 (zh)
KR (1) KR100555367B1 (zh)
CN (2) CN1121397C (zh)
AT (1) ATE235473T1 (zh)
AU (1) AU1484799A (zh)
BR (1) BR9812895B1 (zh)
DE (2) DE19744401A1 (zh)
DK (1) DK1021420T3 (zh)
ES (1) ES2191357T3 (zh)
HU (1) HU228840B1 (zh)
IL (1) IL134875A (zh)
MX (1) MX212965B (zh)
WO (1) WO1999018086A1 (zh)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001046158A1 (de) * 1999-12-21 2001-06-28 Bayer Aktiengesellschaft Verfahren zur herstellung eines triazolinthion-derivates
WO2009077497A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077471A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077443A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2010142779A1 (en) 2009-06-12 2010-12-16 Basf Se Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
WO2010146113A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
WO2010146112A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
WO2010146111A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
WO2010149758A1 (en) 2009-06-25 2010-12-29 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
US7902373B2 (en) 2006-12-19 2011-03-08 Pfizer Inc Nicotinamide derivatives
WO2011073145A1 (en) 2009-12-18 2011-06-23 Basf Se Method for producing triazolinthione derivatives and intermediates thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19917617A1 (de) * 1999-04-19 2000-10-26 Bayer Ag -(-)Enantiomeres des 2-[2-(1-Chlor-cyclopropyl)-3-(2-chlorphenyl) 2-hydroxy-propyl]-2,4-dihydro-[1,2,4]-triazol-3-thions
US7771870B2 (en) 2006-03-22 2010-08-10 Sion Power Corporation Electrode protection in both aqueous and non-aqueous electrochemical cells, including rechargeable lithium batteries
US7247408B2 (en) 1999-11-23 2007-07-24 Sion Power Corporation Lithium anodes for electrochemical cells
DE10233171A1 (de) * 2002-07-22 2004-02-12 Bayer Cropscience Ag Kristallmodifikation II des 2-[2-(Chlor-cyclopropyl)-3-(2-chlorphenyl)-2-hydroxy-propyl]-2,4dihydro-3H-1,2,4-triazol-3-thions
JP2011506543A (ja) * 2007-12-19 2011-03-03 ビーエーエスエフ ソシエタス・ヨーロピア アゾリルメチルオキシラン、その使用及びそれを含む薬剤
WO2012146598A1 (en) 2011-04-28 2012-11-01 Basf Se Process for the preparation of 2-substituted 4-amino-2,4-dihydro-[1,2,4]triazole-3-thiones
WO2012146535A1 (en) 2011-04-28 2012-11-01 Basf Se Process for the preparation of 2-substituted 2,4-dihydro-[1,2,4]triazole-3-thiones
CN105949137B (zh) 2016-07-15 2019-01-29 泸州东方农化有限公司 一种丙硫菌唑及其光学活性体的合成方法和中间体
AU2018411551B2 (en) * 2018-03-06 2023-08-17 Upl Ltd A process for preparation of fungicidally active triazole compounds
CN110218197B (zh) * 2019-06-25 2022-10-21 芮城县斯普伦迪生物工程有限公司 利用微通道反应器连续化生产丙硫菌唑的方法及微通道系统

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52113972A (en) * 1976-03-17 1977-09-24 Mitsubishi Chem Ind Ltd Triazolidine derivatives, their preparation, and herbicidal compositio n containing the same
WO1996016048A1 (de) * 1994-11-21 1996-05-30 Bayer Aktiengesellschaft Mikrobizide triazolyl-derivate
EP0784053A1 (de) * 1996-01-15 1997-07-16 Degussa Aktiengesellschaft Verfahren zur Herstellung von Triazolinonherbiziden

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3812967A1 (de) 1987-06-24 1989-01-05 Bayer Ag Azolylmethyl-cyclopropyl-derivate
DE4030039A1 (de) 1990-09-22 1992-03-26 Bayer Ag Verfahren zur herstellung von 2-(1-chlor-cyclopropyl)-1- (2-chlor-phenyl)-3-(1,2,4-triazol-1-yl- propan-2-ol
DE19601189A1 (de) 1996-01-15 1997-07-17 Degussa Verfahren zur Herstellung von 1,2,4-Triazolin-3(2H)-onen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52113972A (en) * 1976-03-17 1977-09-24 Mitsubishi Chem Ind Ltd Triazolidine derivatives, their preparation, and herbicidal compositio n containing the same
WO1996016048A1 (de) * 1994-11-21 1996-05-30 Bayer Aktiengesellschaft Mikrobizide triazolyl-derivate
EP0784053A1 (de) * 1996-01-15 1997-07-16 Degussa Aktiengesellschaft Verfahren zur Herstellung von Triazolinonherbiziden

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 88, no. 11, 13 March 1978, Columbus, Ohio, US; abstract no. 74395, WAKABAYASHI O. ET AL.: "1,2-Substituted-3-alkoxycarboimino-4-substituted s-triazolidine-5-thiones" XP002090974 *
CHEMICAL ABSTRACTS, vol. 95, no. 23, 7 December 1981, Columbus, Ohio, US; abstract no. 203899, GADZHIEV G. ET AL.: "Reaction of ethanol hydrazones with isocyanates" XP002090973 *
ISAMU ARAI: "Reactions of phenylhydrazinium thiocyanate with ketones and aldehydes", BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN., vol. 46, no. 7, 1973, TOKYO JP, pages 2215 - 2218, XP002090972 *
ZH. ORG. KHIM., vol. 17, no. 8, 1981, USSR, pages 1784 - 1785 *

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001046158A1 (de) * 1999-12-21 2001-06-28 Bayer Aktiengesellschaft Verfahren zur herstellung eines triazolinthion-derivates
US6559317B2 (en) 1999-12-21 2003-05-06 Bayer Aktiengesellschaft Method for production of a triazolinethione derivative
US7902373B2 (en) 2006-12-19 2011-03-08 Pfizer Inc Nicotinamide derivatives
WO2009077443A3 (de) * 2007-12-19 2010-02-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077443A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077497A3 (de) * 2007-12-19 2010-01-28 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077471A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077471A3 (de) * 2007-12-19 2010-02-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2009077497A2 (de) * 2007-12-19 2009-06-25 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2010142779A1 (en) 2009-06-12 2010-12-16 Basf Se Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
WO2010146113A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
WO2010146112A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
WO2010146111A1 (en) 2009-06-18 2010-12-23 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
WO2010149758A1 (en) 2009-06-25 2010-12-29 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
WO2011073145A1 (en) 2009-12-18 2011-06-23 Basf Se Method for producing triazolinthione derivatives and intermediates thereof

Also Published As

Publication number Publication date
JP4028172B2 (ja) 2007-12-26
EP1021420A1 (de) 2000-07-26
DE59807672D1 (de) 2003-04-30
CN1515558A (zh) 2004-07-28
CN1121397C (zh) 2003-09-17
DK1021420T3 (da) 2003-07-21
HU228840B1 (en) 2013-06-28
KR20010024242A (ko) 2001-03-26
MXPA00003448A (es) 2000-11-01
US6372916B2 (en) 2002-04-16
IL134875A0 (en) 2001-05-20
HUP0100103A2 (hu) 2001-06-28
EP1021420B1 (de) 2003-03-26
DE19744401A1 (de) 1999-04-15
KR100555367B1 (ko) 2006-03-03
BR9812895B1 (pt) 2009-05-05
MX212965B (es) 2003-02-13
JP2001519336A (ja) 2001-10-23
BR9812895A (pt) 2000-08-08
US20010056187A1 (en) 2001-12-27
AU1484799A (en) 1999-04-27
US6271389B1 (en) 2001-08-07
IL134875A (en) 2003-10-31
ATE235473T1 (de) 2003-04-15
CN1274348A (zh) 2000-11-22
ES2191357T3 (es) 2003-09-01
HUP0100103A3 (en) 2002-08-28
CN1286818C (zh) 2006-11-29

Similar Documents

Publication Publication Date Title
EP1021420B1 (de) Verfahren zur herstellung von triazolinthion-derivaten
EP1030847B1 (de) Verfahren zur herstellung von triazolinthion-derivaten
EP1242388B1 (de) Verfahren zur herstellung eines triazolinthion-derivates
EP1021419B1 (de) Verfahren zur herstellung von triazolinthion-derivaten
EP1030848B1 (de) Verfahren zur herstellung von triazolinthion-derivaten
EP0124009A2 (de) Verfahren zur Herstellung von Oxiranen
EP0000752A2 (de) Alpha-azolysulfide, -sulfoxide und -sulfone, deren Salze und Metallkomplexe, Verfahren zu ihrer Herstellung, sowie sie enthaltende Mittel zur Pilzbekämpfung
EP0054865B1 (de) Substituierte 1-Azolyl-butan-2-one, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide sowie als Zwischenprodukte
EP0124011B1 (de) Verfahren zur Herstellung von Oxiranen
EP0124013B1 (de) Verfahren zur Herstellung von Oxiranen
DE2242454A1 (de) 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19839688A1 (de) Verfahren zur Herstellung von Triazolinthion-Derivaten
DE3329128A1 (de) 3-cycloalkyl-1-(1,3-dioxan-5-yl)-2-(1,2,4-triazol-1-yl)-propan-1-one und -propan-1-ole
EP0173190A2 (de) Verfahren zur Herstellung von 5-Acylpyrimidinen
EP0005794B1 (de) Verfahren zur stereospezifischen bzw. stereoselektiven Herstellung von Imidazolyl-oximetherderivaten und Imidazolyloximderivaten
EP0110116B1 (de) Verfahren zur Herstellung von Keten-O,N-acetalen
EP0290907B1 (de) Verfahren zur Herstellung von Acetylenepoxiden und deren Verwendung
DE3021516C1 (zh)
DE10047111A1 (de) Verfahren zur Herstellung von DELTA·1·-Pyrrolinen
EP0349856A2 (de) Optisch aktive Oxirane
DE3119390A1 (de) 3-substituierte 1-azolyl-3-methyl-1-phenoxy-butan-2-one und -ole, verfahren zu iher herstellung und ihre verwendung als fungizide
EP0088259A2 (de) Azolyl-pyrrolidinone, Verfahren zu deren Herstellung und ihre Verwendung als Fungizide
EP0090936A2 (de) Substituierte Azolylethyl-oximinoalkyl-ether, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 134875

Country of ref document: IL

Ref document number: 98809959.4

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1998958843

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020007003071

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 09509889

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/003448

Country of ref document: MX

WWP Wipo information: published in national office

Ref document number: 1998958843

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020007003071

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1998958843

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1020007003071

Country of ref document: KR